AQR Arbitrage’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

AQR Arbitrage’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-149,885	Closed	-$1.55M	–	857
2023 Q2	$1.55M	Sell	149,885 -115	-0.1%	-$1.18K	0.07%	294
2023 Q1	$1.53M	Sell	150,000 -124,819	-45%	-$1.27M	0.05%	369
2022 Q4	$2.76M	Hold	274,819	–	–	0.07%	346
2022 Q3	$2.7M	Buy	274,819 +136,339	+98%	+$1.34M	0.06%	423
2022 Q2	$1.35M	Buy	138,480 +55,548	+67%	+$543K	0.03%	525
2022 Q1	$809K	Hold	82,932	–	–	0.02%	533
2021 Q4	$804K	Sell	82,932 -88,694	-52%	-$863K	0.02%	733
2021 Q3	$1.67M	Buy	171,626 +51,630	+43%	+$501K	0.05%	324
2021 Q2	$1.16M	Buy	+119,996	New	+$1.17M	0.03%	432

Other funds holding AONC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Arbitrage's AONC Position: Q3 2023 in Review

AQR Arbitrage sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2023, closing a stake of 149,885 shares — an estimated $1.55M sold.

AQR Arbitrage first reported a position in AONC in Q2 2021 and held it in 9 quarters. The position peaked at $2.76M in Q4 2022. 3 funds tracked by Wall St. Rank hold AONC as of Q3 2023.

AQR Arbitrage reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
AQR Arbitrage sold 149,885 American Oncology Network, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.55M.
AQR Arbitrage first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 9 quarters.
AQR Arbitrage's American Oncology Network, Inc. Class A Common Stock position peaked at $2.76M in Q4 2022.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2023.

Based on AQR Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.